window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1');
Logo-bi
Bioimpacts. 2025;15: 31075 | Published on: 2025 Aug 20. doi: 10.34172/bi.31075
PMID: 40922951        PMCID: PMC12413982

Original Article

MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting CPT1A and ACSL4

Chinnatam Phetkong 1,2,3 ORCID, Thammachanok Boonto 2,3, Pannathon Thamjamrassri 2,3, Chaiyaboot Ariyachet 1,2,3 * ORCID, Pisit Tangkijvanich 2,3 ORCID

Cited by CrossRef: 0

1- Li J, Huang Y, Li J, Shi M, Xiao Y, Du F, Hu G. Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities. Mol Cancer. 2026; [Crossref]
2- Xue R, Jia L, Wei M, Li H, Sun J, Zhao T, Ji H. Docosahexaenoic acid (DHA) enhances lipid utilization in adipocytes through PPARĪ±-ACSL4 axis-promoted lipid droplets-mitochondrial coupling in grass carp (Ctenopharyngodon idellus). Food Research International. 2026;229:118517 [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons